Human peripheral and tissue Foxp3-high regulatory T cells in patients with hepatocellular carcinoma [CITE-seq]
Single-cell RNA-seq · human · 33 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Topic
- Hepatocellular carcinomaThis series is part of our curated briefing on it.
- Samples
- 33 samples: 33 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCCHepatology (Baltimore, Md.) · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE307831_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1327378 and SRA study SRP619260. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 33 sample titles: 33 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9232260 PT1, PB, GEM
- GSM9232261 PT1, PB, ADT
- GSM9232262 PT1, PB, TCR
- GSM9232263 PT1, Tissue, GEM
- GSM9232264 PT1, Tissue, ADT
- GSM9232265 PT1, Tissue, TCR
- GSM9232266 PT2, PB, GEM
- GSM9232267 PT2, PB, ADT
- GSM9232268 PT2, PB, TCR
- GSM9232269 PT2, T, GEM
- GSM9232270 PT2, T, ADT
- GSM9232271 PT2, T, TCR
- GSM9232272 PT2, NT, GEM
- GSM9232273 PT2, NT, ADT
- GSM9232274 PT2, NT, TCR
- GSM9232275 PT3, GEM
- GSM9232276 PT3, ADT
- GSM9232277 PT3, TCR
- GSM9232278 PT4, GEM
- GSM9232279 PT4, ADT
- GSM9232280 PT4, TCR
- GSM9232281 PT5, GEM
- GSM9232282 PT5, ADT
- GSM9232283 PT5, TCR
- GSM9232284 PT6, GEM
- GSM9232285 PT6, ADT
- GSM9232286 PT6, TCR
- GSM9232287 PT7, GEM
- GSM9232288 PT7, ADT
- GSM9232289 PT7, TCR
- GSM9232290 PT8, GEM
- GSM9232291 PT8, ADT
- GSM9232292 PT8, TCR
- GSE10143 Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 387 samples same disease briefing · shares hepatocellular
- GSE104580 Using a novel gene signature for predicting the efficacy of the transarterial chemoembolization in patients with hepatocellular carcinoma. 147 samples same disease briefing · shares hepatocellular
- GSE14520 Gene expression data of human hepatocellular carcinoma (HCC) 488 samples same disease briefing · shares hepatocellular
- GSE105130 Comprehensive analysis of Transcriptome Profiles in Hepatocellular Carcinoma patients 52 samples same disease briefing · shares hepatocellular
- GSE107170 Molecular Signature of Hepatitis D Virus-Associated Hepatocellular Carcinoma 307 samples same disease briefing · shares hepatocellular
- GSE109211 Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial 140 samples same disease briefing · shares hepatocellular
- GSE10186 Integrative Transcriptome Analysis Reveals Common Molecular Subtypes of Human Hepatocellular Carcinoma 118 samples same disease briefing · shares hepatocellular
- GSE140228 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma 41 samples same disease briefing · shares hepatocellular
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.